TransMedics Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. 

CEO
Waleed H. Hassanein
CEOWaleed H. Hassanein
Employees
898
Employees898
Headquarters
Andover, Massachusetts
HeadquartersAndover, Massachusetts
Founded
1998
Founded1998
Employees
898
Employees898

TMDX Key Statistics

Market cap
3.74B
Market cap3.74B
Price-Earnings ratio
22.76
Price-Earnings ratio22.76
Dividend yield
Dividend yield
Average volume
769.58K
Average volume769.58K
High today
$112.05
High today$112.05
Low today
$107.51
Low today$107.51
Open price
$110.64
Open price$110.64
Volume
781.93K
Volume781.93K
52 Week high
$156.00
52 Week high$156.00
52 Week low
$88.50
52 Week low$88.50

Stock Snapshot

With a market cap of 3.74B, TransMedics Group(TMDX) trades at $108.03. The stock has a price-to-earnings ratio of 22.76.

During the trading session on 2026-04-28, TransMedics Group(TMDX) shares reached a daily high of $112.05 and a low of $107.51. At a current price of $108.03, the stock is +0.5% higher than the low and still -3.6% under the high.

Trading volume for TransMedics Group(TMDX) stock has reached 781.93K, versus its average volume of 769.58K.

The stock's 52-week range extends from a low of $88.50 to a high of $156.00.

The stock's 52-week range extends from a low of $88.50 to a high of $156.00.

TMDX News

Simply Wall St 22h
Assessing TransMedics Group Valuation After Recent Share Price Swings

Advertisement Why TransMedics Group (TMDX) is back on investors’ radar TransMedics Group (TMDX) has drawn fresh attention after a mixed stretch in the stock,...

Assessing TransMedics Group Valuation After Recent Share Price Swings
TipRanks 4d
TransMedics: Strengthening Leadership in Organ Preservation Through Rigorous Clinical Trials and Normothermic Perfusion Evidence

TransMedics Group, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Josh Jennings from TD Cowen reiterated a Buy rating on t...

Analyst ratings

83%

of 12 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.